Allergy and Immunology · Stockbridge, GA
NPI
1417997339
Since 2006
Specialty
Allergy and Immunology
Code 207K00000X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
830 Eagles Landing Pkwy Ste 203
Stockbridge, GA, 30281
Phone (770) 953-3331
Groups this clinician bills Medicare through
Medicare paid, 2024
$239K
11,641 services
Medicare patients, 2024
243
Average age 73
Drug cost, 2024
$1.9M
4,831 prescriptions
Company payments, 2025
$3,255
From 21 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Francis L McCafferty Jr. was code 95004 (test - miscellaneous), 2,616 times for 36 patients. In total Francis L McCafferty Jr. billed 11,641 services in 24 codes, and Medicare paid $239K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2020-11-12.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 95004 Test - Miscellaneous | Office | 2,616 | 36 | $2.82 | $7,372 |
| 95117 Treatment - Miscellaneous | Office | 399 | 40 | $8.54 | $3,407 |
| 99458 E&M - Miscellaneous | Office | 209 | 18 | $28.74 | $6,008 |
| 96401 Chemotherapy Administration | Office | 189 | 12 | $54.59 | $10K |
| 99214 Office E&M - Established | Office | 152 | 139 | $90.49 | $14K |
| 94010 Pulmonary Function Testing | Office | 137 | 95 | $20.71 | $2,837 |
| 99457 E&M - Miscellaneous | Office | 135 | 18 | $36.64 | $4,947 |
| 99454 E&M - Miscellaneous | Office | 108 | 15 | $34.80 | $3,759 |
| 95024 Test - Miscellaneous | Office | 96 | 19 | $6.27 | $602 |
| 99213 Office E&M - Established | Office | 86 | 73 | $70.49 | $6,062 |
| 99204 Office E&M - New | Office | 45 | 45 | $125.37 | $5,642 |
By year: 2022 $216K for 10,625 services; 2023 $274K for 13,669 services; 2024 $239K for 11,641 services.
Medicare prescription drug claims, 2024
In 2024, the drug Francis L McCafferty Jr. prescribed most often to Medicare patients was Fluticasone Propionate, with 573 prescriptions and refills. In total Francis L McCafferty Jr. wrote 4,831 Medicare prescriptions that cost $1.9M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Fluticasone Propionate Generic | 573 | 975 | 253 | $9,251 |
| Albuterol Sulfate Hfa Albuterol Sulfate | 450 | 622 | 199 | $14K |
| Ipratropium Bromide Generic | 446 | 653 | 186 | $15K |
| Montelukast Sodium Generic | 417 | 869 | 140 | $4,479 |
| Famotidine Generic | 359 | 629 | 134 | $3,334 |
| Prednisone Generic | 267 | 267 | 162 | $619 |
| Methylprednisolone Generic | 213 | 213 | 137 | $1,343 |
| Triamcinolone Acetonide Generic | 190 | 248 | 88 | $1,947 |
| Trelegy Ellipta Fluticasone/Umeclidin/Vilanter | 178 | 218 | 32 | $136K |
| Epinephrine Generic | 152 | 182 | 99 | $31K |
| Hydroxyzine Hcl Generic | 149 | 207 | 73 | $2,068 |
| Azelastine Hcl Generic | 136 | 230 | 63 | $5,001 |
| Wixela Inhub Fluticasone Propion/Salmeterol | 104 | 152 | 26 | $13K |
| Symbicort Budesonide/Formoterol Fumarate | 73 | 109 | 23 | $23K |
| Levocetirizine Dihydrochloride Generic | 62 | 128 | 19 | $1,154 |
Brand drugs: 1,230 claims; generic drugs: 3,601 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Francis L McCafferty Jr. $3,255 ($3,255 in general payments such as food, travel and fees) from 21 companies. The largest payer was Genzyme Corporation with $564.
| Company | Payments | Amount |
|---|---|---|
| Genzyme Corporation SNY | 18 | $564 |
| CSL Behring CSL.AX | 16 | $413 |
| Novartis Pharmaceuticals Corporation NVS | 18 | $391 |
| AstraZeneca Pharmaceuticals LP AZN | 11 | $250 |
| Takeda Pharmaceuticals U.S.A., Inc. TAK | 8 | $235 |
| GlaxoSmithKline, LLC. GSK | 15 | $201 |
| Regeneron Healthcare Solutions, Inc. REGN | 7 | $179 |
| Amgen Inc. AMGN | 9 | $175 |
| BioCryst US Sales Co., LLC | 8 | $149 |
| Pfizer Inc. PFE | 5 | $135 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.